
Wai Chun Bio-Technology Investor Relations Material
Latest events

H1 2025
27 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Wai Chun Bio-Technology Limited
Access all reports
Wai Chun Bio-Technology Limited is a Hong Kong-based investment holding company engaged in the trading and distribution of modified starch and other biochemical products. The company’s operations include sourcing, processing, and selling agricultural and industrial-grade starch products used in food processing, paper manufacturing, textiles, and other industrial applications. Wai Chun Bio-Technology also explores opportunities in related sectors to diversify its business portfolio. The company is headquartered in Hong Kong, and its shares are listed on the HKEX.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
660
Country
🇭🇰 Hong Kong